The Silver Book: Thrombosis Briefing

Each year close to 1.8 million Americans are diagnosed with atrial fibrillation, have a stroke, or experience a venous thromboembolism event. These can all be caused by or be the result of thrombosis–the formation of a blood clot in a blood vessel.

Join the Alliance for Aging Research, in partnership with the Preventive Cardiovascular Nurses Association and StopAfib.org, as they discuss the latest volume of the Alliance's Silver Book, which shines the spotlight on the human and economic burden of these and other types of thrombosis, and explores the value of innovation in reducing these burdens.

The Alliance will also announce a related effort–the Afib Optimal Treatment Task Force, which has formed to ensure that appropriate guidelines for the treatment of afib are released and translated into practice.

WELCOME & INTRODUCTIONS

Daniel Perry, President & CEO
Alliance for Aging Research

Sue Koob, MS, MPA, Chief Executive Officer
Preventive Cardiovascular Nurses Association

Mellanie True Hills, Founder & CEO
StopAfib.org and the American Foundation for Women's Health

SPEAKERS

Janet Long, MSN, ACNP, FAHA, CLS, FPCNA, Cardiology Nurse Practitioner
Rhode Island Cardiology Center
Past President of Preventive Cardiovascular Nurses Association

J. Jaime Caro, MDCM, FRCPC, FACP, Senior Vice President
United BioSource Corporation

Mellanie True Hills, Atrial Fibrillation Patient
Founder & CEO, StopAfib.org and the American Foundation for Women's Health

AFIB OPTIMAL TREATMENT TASK FORCE ANNOUNCEMENT

Daniel Perry, President & CEO
Alliance for Aging Research

This briefing will be a widely attended event with a meal value less than $50.

This briefing is brought to you in partnership with:

Preventive Cardiovascular Nurses Association

StopAfib.org

The Silver Book: Thrombosis is supported by:

Daiichi-Sankyo